RPL17 and Hypercholesterolemia: In conclusion, our results highlight the dual role of co-stimulatory and co-inhibitory signals in the control of both pro-atherogenic and atheroprotective T cell activation in hypercholesterolemia, and corroborate a critical role of PD-1 signaling in limiting atherogenesis.